AstraZeneca PLC - SWOT Analysis - New Research Report on Companies and Markets

Aug. 16, 2008 - PRLog -- AstraZeneca PLC - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

AstraZeneca was formed in 1999 by the merger of Swedish-based Astra AB and UK-based Zeneca Group Plc. The company is the second largest UK pharmaceutical player (behind GlaxoSmithKline) and is headquartered in London. AstraZeneca has a strong presence in the US and retains a significant presence in Sweden as a legacy of Astra AB. The publicly run company employs around 66,000 people worldwide. The company recorded revenues of $26,475 million during the fiscal year ended December 2006, an increase of 10.5% over 2005. The operating profit of the company was $8,216 million during fiscal year 2006, an increase of 26.4% over 2005. The net profit was $6,043 million in fiscal year 2006, an increase of 28.4% over 2005.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information availablehttp://www.companiesandmarkets.com/Summary-Company-Profil...